GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Nyxoah S.A.
Nyxoah is a medical device company developing a miniature implant for the treatment of sleep apnea. Its stock price is a bet on its innovative solution for a huge market. The stock price reflects high volatility and dependence on clinical trial results and regulatory approvals.
Share prices of companies in the market segment - Medical instruments
Nyxoah S.A. is a Belgian medical device company that has developed a unique implantable system for the treatment of obstructive sleep apnea. We've categorized it as a "Medical Instruments" company. The chart below shows how investors view new technologies for treating common sleep disorders.
Broad Market Index - GURU.Markets
Nyxoah is a Belgian medical company that has developed a unique implantable system for the treatment of obstructive sleep apnea. As a component of the GURU.Markets index, it represents the sleep disorder treatment innovation sector. The chart below shows the US market. See how this company's stock compares to the US market.
Change in the price of a company, segment, and market as a whole per day
NYXH - Daily change in the company's share price Nyxoah S.A.
Shares of Nyxoah, a manufacturer of sleep apnea treatment devices, exhibit high volatility, as measured by change_co. This reflects sensitivity to clinical data and regulatory decisions. This metric is important for analyzing the medical technology sector on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Medical instruments
Nyxoah S.A. is a medical device company. This chart illustrates the high volatility of the MedTech industry. Comparing it to NYXH, which focuses on sleep apnea treatment, helps us understand how its innovative products contribute to its volatility.
Daily change in the price of a broad market stock, index - GURU.Markets
Nyxoah is a European company that has developed a miniature implant for treating sleep apnea. This medtech company's shares are driven by news of clinical trials and approvals in various countries. Its unique story is part of a broader mosaic of volatility in the innovative healthcare sector.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Nyxoah S.A.
Nyxoah S.A.'s year-over-year performance is a story about the commercialization of its system for treating obstructive sleep apnea. Its 12-month market cap depends on progress toward FDA approval and success in Europe. Its subcutaneous neurostimulator offers a unique solution for patients unable to use traditional CPAP therapy.
Annual dynamics of market capitalization of the market segment - Medical instruments
Nyxoah S.A. is a medical device company developing an implantable device for the treatment of sleep apnea. Its innovative technology is its key advantage. The graph shows how its commercialization efforts, the growing adoption of its technology, and competition are impacting its performance in the sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Nyxoah is a biotech company whose future hinges on the success of its sleep apnea implant. Its stock price (ADR) is completely disconnected from economic cycles. The chart reflects medical events—news about clinical trials and regulatory decisions—rather than macroeconomic data.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Nyxoah S.A.
The market capitalization of Nyxoah S.A., a company specializing in medical devices for the treatment of sleep apnea, closely reflects its monthly dynamics (Perf_Month_Co), which are linked to its operating cycles. Price fluctuations reflect the market's reaction to clinical trials, regulatory approvals, and the pace of commercial launch of its innovative implantable device. This is a barometer of expectations regarding the speed of product penetration.
Monthly dynamics of market capitalization of the market segment - Medical instruments
Nyxoah S.A. has developed a unique implant for the treatment of obstructive sleep apnea. The medical technology sector for sleep disorders is large and growing. The industry dynamics in the graph reflect the general interest in new solutions for this common problem. Nyxoah aims to fill its niche by offering a less invasive and more comfortable alternative to existing methods.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Nyxoah S.A. is a medical device company that has developed a unique implantable system for the treatment of obstructive sleep apnea. Its business depends on the acceptance of its technology by doctors and patients. The broader market graph serves as a backdrop to assess the market penetration of its innovative solution for this common health problem.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Nyxoah S.A.
Nyxoah S.A. is a medical technology company developing an implantable system for the treatment of obstructive sleep apnea. Its weekly stock price is volatile, driven by news about clinical trials and regulatory approvals in Europe and the US.
Weekly dynamics of market capitalization of the market segment - Medical instruments
Nyxoah has developed a miniature implantable device for treating sleep apnea. This is an innovative solution in a large market. The company's success depends on its acceptance by doctors and patients. The chart shows how much its stock price is driven by product news rather than by general trends in the medical device sector.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Nyxoah is a manufacturer of innovative medical equipment for sleep apnea treatment. It's a rapid growth story in the stable healthcare sector. The chart below shows how its shares, driven by the introduction of new technology, are more volatile and outperform the broader market.
Market capitalization of the company, segment and market as a whole
NYXH - Market capitalization of the company Nyxoah S.A.
The market capitalization chart of Nyxoah, a medical company developing a sleep apnea implant, reflects its competition with Inspire Medical Systems. Its market valuation shows how investors weigh the potential of its technology against its competitor's already entrenched position. This is a bet that there's room for multiple players in this large market.
NYXH - Share of the company's market capitalization Nyxoah S.A. within the market segment - Medical instruments
Nyxoah is a medical company that has developed a miniature implant for the treatment of obstructive sleep apnea. Its market share is still small, but its technology is groundbreaking. The chart shows the impact of this innovator, which offers a new, less invasive alternative to existing treatments.
Market capitalization of the market segment - Medical instruments
The graph below shows the overall value of the medical device sector. Nyxoah is a Belgian company that has developed a miniature implant for the treatment of sleep apnea that stimulates the hypoglossal nerve. The dynamics of this market reflect the search for new solutions for this common problem. Nyxoah competes with Inspire Medical, offering its unique technology.
Market capitalization of all companies included in a broad market index - GURU.Markets
Nyxoah has developed a miniature implant for sleep apnea treatment that stimulates the hypoglossal nerve. Its capitalization is a bet on a new generation of sleep therapy devices. The chart below shows the economic impact of innovation in this important medical field.
Book value capitalization of the company, segment and market as a whole
NYXH - Book value capitalization of the company Nyxoah S.A.
Nyxoah's foundation is its intellectual property and manufacturing assets for the creation of a miniaturized implantable system for treating sleep apnea. This chart tells the story of a medical company that, after receiving approval in Europe and conducting trials in the US, is building its resources for the global commercialization of its technology.
NYXH - Share of the company's book capitalization Nyxoah S.A. within the market segment - Medical instruments
Nyxoah has developed a miniature implant for treating sleep apnea. The chart shows its share of real assets. These are its R&D centers and manufacturing facilities, where they create a unique neurostimulation system, which is the physical embodiment of their technology.
Market segment balance sheet capitalization - Medical instruments
Nyxoah, which manufactures sleep apnea devices, is a capital-intensive business requiring investment in R&D and production. The chart below shows the total value of assets in the medical device sector, providing a backdrop for assessing its base.
Book value of all companies included in the broad market index - GURU.Markets
Nyxoah S.A. has developed a miniature implant for the treatment of obstructive sleep apnea. The company's assets include its manufacturing and R&D capabilities. Its stake in BCap_All provides the necessary resources to develop a technology that could offer a less invasive and more comfortable solution for millions of patients.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Nyxoah S.A.
Nyxoah is a medical technology company. Its high premium is a bet on its unique implant for treating obstructive sleep apnea, which is a less invasive alternative to existing treatments.
Market to book capitalization ratio in a market segment - Medical instruments
Nyxoah is a medical technology company that has developed an implantable system for the treatment of obstructive sleep apnea. Its value lies in its innovative technology. The chart shows the high premium investors are paying for the potential of its solution in a large and underserved market.
Market to book capitalization ratio for the market as a whole
Nyxoah has developed a miniature implantable device for treating sleep apnea. It's an innovative medical technology. This chart clearly illustrates the premium investors are willing to pay for technologies that address common health problems, completely ignoring the company's current book value.
Debts of the company, segment and market as a whole
NYXH - Company debts Nyxoah S.A.
Nyxoah S.A., a company that has developed an implantable system for the treatment of obstructive sleep apnea, is using debt financing to commercialize its technology. The capital is needed to conduct clinical trials, obtain approvals in various countries, and create the commercial infrastructure to bring the product to market.
Market segment debts - Medical instruments
Nyxoah has developed a miniature implantable device for the treatment of obstructive sleep apnea. Bringing such an innovative medical device to market requires significant investment in clinical trials and regulatory approvals in various countries. This chart shows how the company finances this complex and costly process.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Nyxoah S.A.
Nyxoah has developed a miniature implant for treating sleep apnea. Bringing such an innovative medical device to market requires significant investment in clinical trials and marketing. This chart illustrates the company's reliance on debt to commercialize its technology, a key factor in assessing its financial risk.
Market segment debt to market segment book capitalization - Medical instruments
Nyxoah S.A. is a medical technology company that has developed an implantable system for the treatment of obstructive sleep apnea. This chart shows debt trends in the medical device sector. It helps assess how the company is financing the commercialization of its unique technology in the European and American markets, and how its debt strategy compares to its competitors.
Debt to book value of all companies in the market
Nyxoah S.A. develops and commercializes an implantable system for the treatment of obstructive sleep apnea. Bringing a new medical device to market is an expensive process, requiring investment in clinical trials and marketing. This chart helps understand Nyxoah's chosen funding path: a conservative, equity-based approach, or a more aggressive, debt-based approach to accelerate growth.
P/E of the company, segment and market as a whole
P/E - Nyxoah S.A.
Nyxoah S.A. is a medical technology company developing an implantable device for the treatment of obstructive sleep apnea. This chart shows investor expectations for its unique solution in a huge market. The valuation is based not on current revenue, but on the future commercial potential of its technology.
P/E of the market segment - Medical instruments
This industry chart for medical device manufacturers serves as a benchmark for Nyxoah. It reflects the generally high expectations for medical innovation. Comparisons with it help understand whether Nyxoah's unique technology for treating obstructive sleep apnea is considered more or less promising than that of its competitors, including giant Inspire Medical.
P/E of the market as a whole
Nyxoah S.A. is a European company that has developed a miniature implantable device for treating sleep apnea. It competes in a promising but challenging market. This chart of overall sentiment in the medtech sector shows whether investors are willing to fund European companies undergoing the long and expensive process of entering the US market.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Nyxoah S.A.
Nyxoah is a medical technology company developing an implantable system for the treatment of obstructive sleep apnea. This chart shows the company's expected commercialization. This estimate depends on the success of clinical trials, regulatory approval in key regions (the US and Europe), and the company's ability to convince physicians and patients of the effectiveness of its technology.
%20P%2FE%20Nyxoah%20S.A.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Nyxoah-S.A.&v=1772688697656 "Chart of the company's future (projected) P/E Nyxoah S.A.")
Future (projected) P/E of the market segment - Medical instruments
Nyxoah S.A. is a medical device company focused on developing solutions for the treatment of obstructive sleep apnea. This chart reflects investor expectations for the company's profitability relative to the sector. It provides an insight into the market perception of its innovative hypoglossal nerve stimulation technology.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Medical-instruments&v=1772688697661 "Future (projected) P/E graph of the market segment - Medical instruments")
Future (projected) P/E of the market as a whole
Nyxoah has developed a miniature implantable system for the treatment of obstructive sleep apnea. For a company with an innovative medical device like Nyxoah, this market sentiment graph is important. Their commercial success depends on the acceptance of the technology by doctors and patients, but market optimism facilitates raising capital for marketing and further research.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772688697667 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Nyxoah S.A.
Nyxoah S.A. is a medical technology company that has developed a unique system for treating obstructive sleep apnea using hypoglossal nerve stimulation. This chart shows the company's financial results during the commercialization phase of its innovative implantable device.
Profit of companies in the market segment - Medical instruments
Nyxoah has developed a miniature implantable system for the treatment of obstructive sleep apnea. This chart shows the profitability of the medical device sector. For NYXH, this reflects the huge need for new, more convenient methods of treating apnea. Their technology offers an alternative to bulky CPAP machines, which could change the market.
Overall market profit
Nyxoah is a Belgian company that has developed a miniature implantable system for the treatment of obstructive sleep apnea. It is an innovative solution to a major problem. The company's growth depends on regulatory approvals and the acceptance of its technology by the medical community. This graph of overall corporate profitability does not reflect the specifics of this medical market.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Nyxoah S.A.
Nyxoah is a Belgian company that has developed a miniature implantable system for the treatment of obstructive sleep apnea. The revenue forecast presented here reflects expectations for the commercialization of this technology in Europe and approval in the US. This is a bet on a new approach to treating a very common condition.
%20profit%20of%20the%20company%20Nyxoah%20S.A.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Nyxoah-S.A.&v=1772688697674 "Graph of future (projected) profit of the company Nyxoah S.A.")
Future (predicted) profit of companies in the market segment - Medical instruments
Nyxoah S.A. has developed a miniature implantable stimulator for the treatment of obstructive sleep apnea. The revenue forecast for this sector depends on the acceptance of this new technology by doctors and patients. This chart reflects analysts' expectations regarding the commercial potential of innovative solutions for treating one of the most common sleep disorders.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Medical-instruments&v=1772688697674 "Graph of future (predicted) profits of companies in a market segment - Medical instruments")
Future (predicted) profit of the market as a whole
Nyxoah has developed a miniature implantable device for the treatment of obstructive sleep apnea. The company's growth depends on clinical data and product commercialization. The market revenue projections presented here impact the overall investment environment in the medical technology sector and healthcare budgets.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772688697675 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Nyxoah S.A.
Nyxoah is a Belgian company that has developed a miniature implantable device for the treatment of obstructive sleep apnea. This chart shows how the market estimates the sales revenue of this innovative technology. The estimate depends on the success of its commercialization in Europe and the US, as well as competition from other treatments.
P/S market segment - Medical instruments
Nyxoah is a medical technology company that has developed a unique system for treating obstructive sleep apnea. Its implantable device stimulates the hypoglossal nerve. This chart shows the average revenue estimate for the sector, helping to understand the premium the market is paying for Nyxoah's innovative technology and growth potential.
P/S of the market as a whole
Nyxoah is a medical technology company that has developed an implantable system for the treatment of obstructive sleep apnea. This innovative solution is available to patients who are not helped by traditional treatments. The company's growth depends on the adoption of its technology. This chart provides a general market context for assessing investor sentiment regarding revenue prospects in the disruptive medical device sector.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Nyxoah S.A.
Nyxoah S.A. has developed an implantable system for the treatment of obstructive sleep apnea, a common breathing disorder. This chart shows how investors estimate the company's future sales, reflecting the potential of this innovative technology to improve the quality of life for millions of people.
%20P%2FS%20Nyxoah%20S.A.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Nyxoah-S.A.&v=1772688697696 "The graph of the company's future (projected) P/S Nyxoah S.A.")
Future (projected) P/S of the market segment - Medical instruments
Nyxoah S.A. has developed a unique implantable device for the treatment of obstructive sleep apnea, a condition in which breathing stops during sleep. This chart reflects the investors' confidence in its minimally invasive technology and its potential to offer an effective solution for millions of patients.
%20P%2FS%20market%20segment%20graph%20-%20Medical%20instruments&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Medical-instruments&v=1772688697706 "Future (projected) P/S market segment graph - Medical instruments")
Future (projected) P/S of the market as a whole
Nyxoah S.A. is developing an implantable system for the treatment of obstructive sleep apnea. As a medical technology company, their growth depends on market acceptance of their product. This graph, reflecting the stability of the healthcare system, is important. Economic growth provides funding that allows clinics and patients to access new, innovative treatments.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772688697716 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Nyxoah S.A.
Nyxoah is a medical device company that has developed a miniature implantable system for the treatment of obstructive sleep apnea. This chart shows initial revenue from sales of its innovative device in Europe. Revenue growth will depend on successful commercialization in the US and the acceptance of its technology by doctors and patients as an alternative to traditional treatments.
Sales of companies in the market segment - Medical instruments
Nyxoah is a medical technology company developing a unique therapy for obstructive sleep apnea. Their system is a tiny implant that stimulates the airway nerves during sleep. Their early-stage revenue comes from sales of this innovative device in European markets.
Overall market sales
Nyxoah is a medical technology company that has developed a unique implantable device for the treatment of obstructive sleep apnea. Its system stimulates the hypoglossal nerve, preventing airway obstruction during sleep. This revenue chart includes the healthcare sector, where NYXH offers an innovative solution to a common and serious health problem.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Nyxoah S.A.
Nyxoah has developed a miniature implantable device for the treatment of obstructive sleep apnea, a common breathing disorder. This graph shows analysts' expectations for the adoption of this new technology as an alternative to bulky CPAP machines.
%20sales%20of%20the%20company%20Nyxoah%20S.A.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Nyxoah-S.A.&v=1772688697729 "Schedule of future (projected) sales of the company Nyxoah S.A.")
Future (projected) sales of companies in the market segment - Medical instruments
Nyxoah has developed a miniature implantable device for the treatment of obstructive sleep apnea that stimulates the hypoglossal nerve. This graph shows forecasts for the entire apnea treatment device market, reflecting the need for new, more convenient alternatives to traditional CPAP therapy for the millions of people suffering from this disorder.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Medical-instruments&v=1772688697735 "Schedule of future (projected) sales of companies in the market segment - Medical instruments")
Future (projected) sales of the market as a whole
Nyxoah S.A., a developer of treatments for obstructive sleep apnea, sees this chart as a reflection of investment in medical technology. Rising overall economic forecasts are enabling healthcare systems to implement innovative solutions. Nyxoah's device offers a new approach to treating apnea, attracting the attention of both physicians and investors.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772688697738 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Nyxoah S.A.
Nyxoah S.A. is a medical technology company developing and commercializing a unique system for the treatment of obstructive sleep apnea. Its financial success depends on the acceptance of the technology by doctors and patients. This chart shows how the company balances research and marketing expenses with growing revenue from sales of its innovative product.
Market segment marginality - Medical instruments
Nyxoah has developed a miniature implantable system for the treatment of obstructive sleep apnea. This figure reflects the commercial potential of its innovative solution. Increased operational efficiency will indicate recognition of its technology by the medical community and strong patient demand.
Market marginality as a whole
Nyxoah is a medical technology company developing an implantable device for the treatment of sleep apnea. The company's growth depends on the success of its technology and its market acceptance. This overall profitability chart is not relevant to the specifics of the medical device market, where clinical data and innovation are crucial.
Employees in the company, segment and market as a whole
Number of employees in the company Nyxoah S.A.
Nyxoah is a medical technology company that has developed a unique system for treating obstructive sleep apnea. It consists of a tiny implant that stimulates the hypoglossal nerve to prevent sleep apnea. This graphic shows the team commercializing this innovative and less invasive solution.
Share of the company's employees Nyxoah S.A. within the market segment - Medical instruments
Nyxoah S.A. is a medical technology company developing a unique neurostimulation system for the treatment of obstructive sleep apnea. Implementing such innovative technology requires a large team of clinical specialists working with doctors and patients. This graph demonstrates its potential to become a leader in the emerging field of sleep medicine.
Number of employees in the market segment - Medical instruments
Nyxoah has developed a miniature implantable device to treat obstructive sleep apnea, a common and devastating disorder. This graphic shows a team of engineers and clinicians working to create an innovative solution to a problem affecting millions of people, striving to make therapy more comfortable and effective.
Number of employees in the market as a whole
Nyxoah S.A. is a medical technology company developing solutions for the treatment of obstructive sleep apnea. The economic environment, reflected in the employment graph, is important for the implementation of their innovations. Stable employment provides patients with access to health insurance, which makes it possible to utilize advanced therapeutic systems like those offered by Nyxoah.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Nyxoah S.A. (NYXH)
Nyxoah S.A. is a European company that has developed an implant for treating sleep apnea. This chart represents a MedTech model with global ambitions. Their high market capitalization per employee reflects the market's belief that their unique technology can capture a significant share of a multi-billion dollar market. This is an assessment of potential, not current sales.
%20of%20the%20company%20Nyxoah%20S.A.%20(NYXH)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Nyxoah-S.A.-NYXH&v=1772688697755 "Chart of market capitalization per employee (in thousands of dollars) of the company Nyxoah S.A. (NYXH)")
Market capitalization per employee (in thousands of dollars) in the market segment - Medical instruments
Nyxoah S.A. is a medical technology company that has developed an implantable system for the treatment of obstructive sleep apnea. Its value is determined by the uniqueness of its technology and clinical success. This chart shows how the market values its innovation potential per employee compared to other medical device manufacturers.
%20by%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Medical-instruments&v=1772688697766 "Market capitalization per employee (in thousands of dollars) by market segment - Medical instruments")
Market capitalization per employee (in thousands of dollars) for the overall market
Nyxoah is a medical technology company that has developed a miniature implantable system for the treatment of obstructive sleep apnea. This metric reflects the potential of its innovative solution, demonstrating how the market values a product that could offer a less invasive and more convenient alternative to existing treatments.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772688697769 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Nyxoah S.A. (NYXH)
Nyxoah is a European medical company developing a miniature implant for the treatment of sleep apnea. This graph shows the commercialization phase. They have received approval in Europe and are moving toward the US. The R&D and sales teams currently spend more than they earn. Efficiency will increase as surgeons begin to implement their technology.
%20Chart%20Nyxoah%20S.A.%20(NYXH)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Nyxoah-S.A.-NYXH&v=1772688697771 "Company Profit Per Employee (in thousands of dollars) Chart Nyxoah S.A. (NYXH)")
Profit per employee (in thousands of dollars) in the market segment - Medical instruments
Nyxoah S.A. is a medical device company that developed Genio, a miniature implant for the treatment of obstructive sleep apnea. The device stimulates the hypoglossal nerve, preventing airway obstruction. This graph represents an industry benchmark. In the medtech implant sector, it reflects how effectively Nyxoah is commercializing this innovative technology among ENT and sleep specialists.
%20in%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Medical-instruments&v=1772688697777 "Chart of profit per employee (in thousands of dollars) in the market segment - Medical instruments")
Profit per employee (in thousands of dollars) for the market as a whole
Nyxoah S.A. is a European medical technology company. They have developed a miniature implant (Genio) for the treatment of obstructive sleep apnea. It stimulates the hypoglossal nerve. This involves complex R&D and commercialization. This graph shows the investment (negative return) per employee required to conduct clinical trials and bring this innovative implant to market.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772688697791 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Nyxoah S.A. (NYXH)
Nyxoah has developed a miniature implantable system for the treatment of obstructive sleep apnea. This graph shows the commercialization path of this innovative medical device. Growth in revenue per employee will reflect the successful implementation of this technology in clinical practice and its acceptance by both physicians and patients as an alternative to existing treatments.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Nyxoah-S.A.-NYXH&v=1772688697795 "Sales chart per company employee Nyxoah S.A. (NYXH)")
Sales per employee in the market segment - Medical instruments
Nyxoah (NYXH) is a medical technology company developing a miniature implant for the treatment of sleep apnea (nerve stimulation). It's an innovative R&D company. This chart shows how effective their team of engineers and clinicians is (currently) in generating revenue (which could be small or nonexistent) compared to established CPAP device manufacturers.
Sales per employee for the market as a whole
Nyxoah is a medical company developing an innovative solution for treating sleep apnea. Instead of a CPAP mask, they've created a tiny implantable neurostimulator. This is an R&D company. This chart shows how their team of engineers and doctors is beginning to commercialize this technology (primarily in Europe).
Short shares by company, segment and market as a whole
Shares shorted by company Nyxoah S.A. (NYXH)
Nyxoah (NYXH) is a medical device company developing an implantable system (Genio) for the treatment of obstructive sleep apnea (OSA) through hypoglossal nerve stimulation. This chart shows bearish bets. The rise in shorts reflects investor concerns about competition (from Inspire Medical) or skepticism about how many patients will opt for the surgical implant.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Nyxoah-S.A.-NYXH&v=1772688697801 "Short Shares Chart for the Company Nyxoah S.A. (NYXH)")
Shares shorted by market segment - Medical instruments
Nyxoah (NYXH) is a medical device company developing a unique implantable system for the treatment of obstructive sleep apnea (OSA). This chart reflects the overall sentiment in the medical device sector, showing how many investors doubt the commercial success of their niche technology in a competitive environment.
Shares shorted by the overall market
Nyxoah (NYXH) is developing an implantable device for sleep apnea. Although it's a serious condition, the company offers a *new* and expensive technology. When this chart shows rising fears, investors fear two things: that patients will prefer older CPAP machines, and that hospitals will freeze budgets for innovation.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Nyxoah S.A. (NYXH)
Nyxoah is a medical technology company developing a miniature implant for the treatment of obstructive sleep apnea (a competitor to Inspire). This is a highly speculative R&D bet. This chart measures the level of hype. It shows when the euphoria from trial data (overbought) or doubts about the technology (oversold) peak.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Nyxoah-S.A.-NYXH&v=1772688697849 "RSI 14 indicator chart for the company's stock Nyxoah S.A. (NYXH)")
RSI 14 Market Segment - Medical instruments
Nyxoah is a medical technology company developing a unique hypoglossal nerve stimulation system (Genio) for the treatment of obstructive sleep apnea. Their implant is one of the smallest on the market. This graph measures the overall momentum in the medical device sector and helps assess whether this innovative sleep therapy segment is overheating.
RSI 14 for the overall market
Nyxoah (NYXH), a manufacturer of implants for sleep apnea treatment. This chart is an indicator of elective surgeries. During periods of euphoria and stability, patients confidently undergo expensive elective surgeries. During periods of market panic and rising unemployment, people, fearing loss of insurance, postpone "non-urgent" surgeries.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast NYXH (Nyxoah S.A.)
Nyxoah is a Belgian medical device company developing Genio, a miniature, battery-free implant for hypoglossal nerve stimulation (treatment for sleep apnea). This chart shows the speculative average price target from analysts, based on their assessment of this innovative technology and clinical trial data.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-NYXH-Nyxoah-S.A.&v=1772688697920 "A chart showing analyst consensus forecasts for the expected stock price. NYXH (Nyxoah S.A.)")
The difference between the consensus estimate and the actual stock price NYXH (Nyxoah S.A.)
Nyxoah is a Belgian medtech company. They've developed a tiny implant (Genio) for treating sleep apnea (snoring). It stimulates the hypoglossal nerve, preventing the tongue from blocking breathing. They compete with Inspire Medical. This chart shows how much analysts believe in their technology and their ability to capture share in this large market.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-NYXH-Nyxoah-S.A.&v=1772688697921 "A chart showing the difference between the consensus forecast and the actual stock price. NYXH (Nyxoah S.A.)")
Analyst consensus forecast for stock prices by market segment - Medical instruments
Nyxoah (NYXH) is a European company that has developed a unique miniature implant for treating sleep apnea (using nerve stimulation, similar to the Inspire). This chart shows analysts' overall expectations for the medical devices sector. It reflects whether experts believe the market for high-tech sleep solutions will grow.
Analysts' consensus forecast for the overall market share price
Nyxoah S.A. is a European medical company that has developed a miniature implant (Genio) for stimulating the hypoglossal nerve, intended for the treatment of sleep apnea. This chart shows the overall market sentiment. For Nyxoah, a company with an innovative but expensive device, overall optimism is important for funding commercialization and competition in the apnea market.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Nyxoah S.A.
Nyxoah is a MedTech company attacking sleep apnea (a competitor to Inspire). Their signature product is a minimally invasive implant (Genio) that stimulates the tongue nerve but requires only one incision (under the chin). This chart is a summary of their R&D progress. It reflects their clinical progress (especially in the US) and their chances of winning a share of this multi-billion dollar market.
AKIMA Market Segment Index - Medical instruments
Nyxoah is a medical device company that developed Genio, an implantable system for the treatment of obstructive sleep apnea. It stimulates the hypoglossal nerve to keep the airway open. This chart shows the average index for the medical devices sector. It helps assess how Nyxoah's innovative technology compares to the industry average.
The AKIM Index for the overall market
Nyxoah is a medtech company that developed an implant (Genio) for treating sleep apnea. It competes with Inspire Medical. This chart, which reflects the market average, is just a backdrop. It helps assess how this entry into the US market in a growing segment compares to overall macroeconomic trends.
